tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (DE:JNY)
:JNY
Germany Market

JW (Cayman) Therapeutics Co. Ltd. (JNY) Financial Statements

Compare
0 Followers

JW (Cayman) Therapeutics Co. Ltd. Financial Overview

JW (Cayman) Therapeutics Co. Ltd.'s market cap is currently €92.88M. The company's EPS TTM is €-0.10687134599999999; its P/E ratio is ―; JW (Cayman) Therapeutics Co. Ltd. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 158.22M¥ 173.86M¥ 145.70M¥ 30.80M¥ 0.00
Gross Profit¥ 77.32M¥ 88.22M¥ 58.76M¥ 9.04M¥ 0.00
Operating Income¥ -466.15M¥ -789.61M¥ -697.17M¥ -771.72M¥ -467.86M
EBITDA¥ -381.58M¥ -655.75M¥ -752.27M¥ -738.70M¥ -454.04M
Net Income¥ -590.62M¥ -768.00M¥ -846.13M¥ -702.33M¥ -1.66B
Balance Sheet
Cash & Short-Term Investments¥ 757.38M¥ 1.01B¥ 1.39B¥ 1.84B¥ 2.63B
Total Assets¥ 1.68B¥ 2.15B¥ 2.79B¥ 3.12B¥ 3.78B
Total Debt¥ 422.40M¥ 318.80M¥ 279.13M¥ 147.03M¥ 123.59M
Net Debt¥ -334.97M¥ -687.11M¥ -1.10B¥ -1.69B¥ -2.51B
Total Liabilities¥ 511.20M¥ 462.26M¥ 437.06M¥ 325.75M¥ 349.76M
Stockholders' Equity¥ 1.17B¥ 1.68B¥ 2.35B¥ 2.79B¥ 3.43B
Cash Flow
Free Cash Flow¥ 0.00¥ -413.00M¥ -613.60M¥ -634.28M¥ -385.24M
Operating Cash Flow¥ 0.00¥ -398.42M¥ -536.72M¥ -561.20M¥ -261.00M
Investing Cash Flow¥ 0.00¥ 9.90M¥ -124.08M¥ -137.13M¥ -91.91M
Financing Cash Flow¥ 0.00¥ 275.00K¥ 112.35M¥ -30.62M¥ 2.86B
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Earnings and Revenue History

JW (Cayman) Therapeutics Co. Ltd. Debt to Assets

JW (Cayman) Therapeutics Co. Ltd. Cash Flow

JW (Cayman) Therapeutics Co. Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis